Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.
Industry News
Shionogi Plans Pharmaceutical Research Facility
Shionogi & Co. will begin construction on a new ¥14 billion pharmaceutical research facility on its existing campus in Toyonaka City, Osaka, in fall of 2008. Serving as the center of research operations, the 43,000-sm facility will house world class laboratories and testing equipment in a six-story earthquake resistant facility. Construction is expected to reach completion in spring of 2010 with operations commencing in summer of 2010.
State of California Implements LEAN Prison Hospital Building Program
The State of California is implementing an $8 billion hospital construction program at state prisons. The joint venture program management team is comprised of URS Corp. and Bovis Lend Lease. Featuring integrated project delivery principles and lean construction methodology, the project includes construction of seven California prison hospitals by 2014.
University of Cincinnati Opens Center for Academic Research Excellence
The University of Cincinnati opened the Center for Academic Research Excellence (CARE) on its medical campus in Coryville, Ohio, in August of 2008. The $107.3 million facility features 70,000-sf of health science research laboratories and 17,000-sf of teaching labs. Designed by Studios Architecture of San Francisco and Harley Ellis of Cincinnati, the building is connected by a nine-story glass atrium to the newly renovated Medical Sciences Building (MSB).
UC San Francisco Plans Institute for Regeneration Medicine
The University of California at San Francisco (UCSF) will break ground in fall of 2008 on the 74,832-gsf Institute for Regeneration Medicine on its Parnassus campus. Designed by Rafael Viñoly Architects, the $128-million facility is supported by a $34.8 million grant from the California Institute for Regenerative Medicine (CIRM). Housing multidisciplinary stem cell research, the 46,283-asf project will be comprised of four split-level floors housing wet labs, support and offices.
Bayer Builds Shanghai TDI Plant
Bayer will initiate construction by year-end 2008 on a toluene diisocyanate (TDI) manufacturing plant in Shanghai, China. The facility will begin operations in 2010 with a manufacturing capacity of 700,000 tons per year. TDI is a raw material for the production of polyurethane foam. Bayer, headquartered in Frankfurt, will invest US$3.1 billion in its Shanghai campus by 2012.